Central Vasopressin and Maternal Behavior
中枢加压素和母亲行为
基本信息
- 批准号:7739025
- 负责人:
- 金额:$ 8.84万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-09-15 至 2011-08-31
- 项目状态:已结题
- 来源:
- 关键词:AcuteAdrenal Cortex HormonesAffectAggressive behaviorAnxietyArgipressinAutoradiographyBehaviorBehavior ControlBehavior DisordersBehavioralBrain regionChildChild health careChronicChronic stressComputer Retrieval of Information on Scientific Projects DatabaseDataDatabasesDevelopmentDiseaseDropsEndocrineEnsureEtiologyExposure toFemaleFocus GroupsFunctional Magnetic Resonance ImagingGoalsHealthHealth behaviorHormonesHumanImageIn Situ HybridizationInstructionInvestigationLactationLifeLinkMaternal BehaviorMediatingMessenger RNAMethodsMissionMolecularMood DisordersMothersNational Institute of Child Health and Human DevelopmentNeurohormonesNeurosciencesNeurosecretory SystemsOperative Surgical ProceduresOxytocinOxytocin ReceptorPeptidesPeripheralPersonal SatisfactionPersonsPhysiologicalPhysiologyPostpartum DepressionPostpartum PeriodProductivityProtocols documentationRattusRehabilitation therapyReportingReproductive ProcessResearchResearch PersonnelRisk FactorsRoleStressSystemTechniquesTestingTrainingUnited States National Institutes of HealthVasopressinsWomanacute stressbasecareerdepressiondisabilityindexingmRNA Differential DisplaysmRNA Expressionmaternal aggressionmolecular imagingoffspringparityprogramspublic health relevancepuprelating to nervous systemresponsesocialsocial stressstressor
项目摘要
DESCRIPTION (provided by applicant): The mission of the NICHD is to ensure that every person is bom healthy and wanted, that women suffer no harmful effects from reproductive processes, and that all children have the chance to achieve their full potential for healthy and productive lives, free from disease or disability, and to ensure the health, productivity, independence, and well-being of all people through optimal rehabilitation. Postpartum anxiety and depression- associated disorders can have negative effects on the health of both mother and offspring through effects on maternal behavior, and little is known about the etiology of these disorders. Although chronic stress is a significant risk factor for depression, it is unknown how chronic stress during lactation affects maternal behavior. Recent molecular studies indicate that the neurohormones arginine vasopressin (AVP), oxytocin (OXT), and corticosteroid releasing hormone (CRH) may be involved in the modulation of maternal behavior in lactating rats. It is h3T) 0thesized that the central AVP system may be a potential target for the treatment of postpartum behavioral disorders, as central manipulations of AVP alter behavior. The overall objective of the current protocol is to investigate the role of AVP in postpartum maternal behavior and aggression, and the effects of social stress on this system. The specific aims of the current proposal are to characterize the roles of central AVP, OXT, and CRH in the control of maternal behavior and maternal aggression, investigate the effects of chronic social stressors on these behaviors and central AVP, and investigate a potential AVP-mediated mechanism for the effects of chronic social stress on maternal behavior. These aims will be pursued using behavioral, endocrine, and molecular methods to quantify the effects of chronic social stressors, molecular and imaging (fMRI) techniques to identify the neural regions implicated in the acute and chronic control of maternal behavior, and stereotaxic surgical techniques to manipulate central AVP activity. The overall goal is to gain valuable training in behavioral neuroscience techniques and study the neuropeptidergic control of behavior. The long term career goal is to develop new targets and treatments for behavioral disorders of mothers.
PUBLIC HEALTH RELEVANCE (See instructions): Although it is clear that the behavior of the mother affects the behavior and health of her children, very few studies have been directed at determining the causes of postpartum behavioral disorders. This application will help to ensure the health of mothers and their children by investigating potential mechanisms for the control of maternal behavior and causes for postpartum behavioral disorders.
描述(由申请人提供):NICHD 的使命是确保每个人出生时都是健康和想要的,妇女不会受到生殖过程的有害影响,并且所有儿童都有机会充分发挥其健康和生产的潜力生命,免受疾病或残疾的困扰,并通过最佳康复确保所有人的健康、生产力、独立性和福祉。产后焦虑和抑郁相关疾病可能通过影响母亲行为而对母亲和后代的健康产生负面影响,但人们对这些疾病的病因知之甚少。尽管慢性压力是抑郁症的一个重要危险因素,但目前尚不清楚哺乳期间的慢性压力如何影响母亲的行为。最近的分子研究表明,神经激素精氨酸加压素(AVP)、催产素(OXT)和皮质类固醇释放激素(CRH)可能参与哺乳大鼠母性行为的调节。据推测,中央 AVP 系统可能是治疗产后行为障碍的潜在目标,因为 AVP 的中央操作会改变行为。当前协议的总体目标是调查 AVP 在产后母亲行为和攻击行为中的作用,以及社会压力对该系统的影响。当前提案的具体目标是描述中枢 AVP、OXT 和 CRH 在控制母亲行为和母亲攻击性中的作用,研究慢性社会压力源对这些行为和中枢 AVP 的影响,并研究潜在的 AVP-慢性社会压力对母亲行为影响的中介机制。这些目标将通过使用行为、内分泌和分子方法来量化慢性社会压力源的影响,使用分子和成像(fMRI)技术来识别与急性和慢性控制产妇行为有关的神经区域,并使用立体定位手术技术来实现操纵中枢 AVP 活动。总体目标是获得行为神经科学技术的宝贵培训并研究行为的神经肽控制。长期职业目标是开发母亲行为障碍的新目标和治疗方法。
公众健康相关性(参见说明):虽然很明显母亲的行为会影响孩子的行为和健康,但很少有研究直接确定产后行为障碍的原因。该应用程序将通过研究控制孕产妇行为的潜在机制和产后行为障碍的原因,有助于确保母亲及其孩子的健康。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
BENJAMIN C NEPHEW其他文献
BENJAMIN C NEPHEW的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('BENJAMIN C NEPHEW', 18)}}的其他基金
相似国自然基金
孕期促肾上腺皮质激素释放激素(CRH)通过引起DNA甲基化发生程序化稳定改变长期影响婴幼儿神经行为发育
- 批准号:
- 批准年份:2021
- 资助金额:30 万元
- 项目类别:
自主要求剖宫产对子代工作记忆的影响及低位GCs与海马CRH-CRHR1信号互作机制
- 批准号:81872630
- 批准年份:2018
- 资助金额:58.0 万元
- 项目类别:面上项目
应用H295R细胞研究SF-1、ACTHR对肾上腺皮质激素分泌调控的影响机制
- 批准号:81200579
- 批准年份:2012
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
慢性应激状态下酸敏感离子通道对下丘脑促肾上腺皮质激素释放激素的影响
- 批准号:81100558
- 批准年份:2011
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
中药中CRF受体结合成份的分离及其影响糖尿病肾病进程的研究
- 批准号:81001626
- 批准年份:2010
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
相似海外基金
An Inhaled Microbiome-Targeted Biotherapeutic for Treatment of COPD
一种吸入性微生物组靶向生物治疗药物,用于治疗慢性阻塞性肺病
- 批准号:
10600887 - 财政年份:2023
- 资助金额:
$ 8.84万 - 项目类别:
Dose escalation clinical trial of high-dose oral montelukast to inform future RCT in children with acute asthma exacerbations
大剂量口服孟鲁司特的剂量递增临床试验为哮喘急性发作儿童的未来随机对照试验提供信息
- 批准号:
10649012 - 财政年份:2023
- 资助金额:
$ 8.84万 - 项目类别:
Defining a gene expression signature of airway disease, COPD exacerbations, and response to treatment
定义气道疾病、COPD 恶化和治疗反应的基因表达特征
- 批准号:
10733573 - 财政年份:2023
- 资助金额:
$ 8.84万 - 项目类别:
A Mixed Methods Evaluation of Developing COPD Exacerbations in the MARC Cohort
MARC 队列中 COPD 加重的混合方法评估
- 批准号:
10605385 - 财政年份:2023
- 资助金额:
$ 8.84万 - 项目类别:
A Novel Small Molecule Therapeutic for Acute Graft Versus Host Disease
一种治疗急性移植物抗宿主病的新型小分子疗法
- 批准号:
10759657 - 财政年份:2023
- 资助金额:
$ 8.84万 - 项目类别: